POMDOCTOR Ltd
corporate_fare Company Profile
POMDOCTOR Ltd (NASDAQ:POM) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 13 items for POM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-10, rated 7/10. Across its 13 most recent items scored 7 or higher, the top rating is 9/10, with 8 rated 8 or above. Recent SEC coverage for POM spans 6-K, 20-F.
Recent high-impact activity:
- POMDOCTOR Unveils US$30M Capital Raise Plan Ahead of H.C. Wainwright Conference
- POMDOCTOR Proposes ADR Termination, Direct Nasdaq Listing, and 10-to-1 Share Consolidation
- POMDOCTOR Details Four-Tier Revenue Model and FY2025 Revenue of RMB399.9M Amid AI Pivot
- POMDOCTOR Resolves Nasdaq Delisting Threat by Regaining Compliance
- Pomdoctor Pivots to AI-Enabled Predictive Healthcare Infrastructure Amid Financial Distress
Financial Snapshot
Insider Transactions
POM files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.